Edwards Lifesciences (EW) Short-Term Debt issuances (2010 - 2013)

Edwards Lifesciences' Short-Term Debt issuances history runs 4 years deep, the most recent figure standing at $372.9 million for Q3 2013.

• On a quarterly basis, Short-Term Debt issuances rose 775.35% year-over-year to $372.9 million in Q3 2013; TTM through Sep 2013 was $900.5 million, a 149.45% increase from a year earlier, with the FY2012 full-year figure at $407.0 million, down 22.64% from the prior year.
• Short-Term Debt issuances grew to $372.9 million in Q3 2013 per EW's latest filing, from $173.9 million in the prior quarter.
• Across five years, Short-Term Debt issuances topped out at $372.9 million in Q3 2013 and bottomed at $5.2 million in Q1 2011.
• The 4-year median for Short-Term Debt issuances is $108.2 million (2010), against an average of $129.4 million.
• Across the five-year window, Short-Term Debt issuances tumbled 91.93% in 2011 and jumped 2815.38% in 2012, its largest moves.
• Year by year, Short-Term Debt issuances stood at $95.2 million in 2010, then soared by 56.93% to $149.4 million in 2011, then soared by 30.79% to $195.4 million in 2012, then jumped by 90.84% to $372.9 million in 2013.
• Per Business Quant, the three latest EW Short-Term Debt issuances figures stand at $372.9 million (Q3 2013), $173.9 million (Q2 2013), and $158.3 million (Q1 2013).